He has a strong academic and research background in pharmacology, with extensive expertise in in-vivo studies utilizing diverse animal models. His research experience includes working with disease models such as cardiotoxicity, myocardial infarction, diabetes, and Alzheimer’s disease. He specializes in designing and conducting experimental protocols to evaluate pharmacological interventions and therapeutic efficacy. In addition to his proficiency in in-vivo methodologies, he is committed to advancing translational research that bridges preclinical findings with clinical applications.